The Nasal Changes Affected by Different Alar Base Suture Techniques After Maxillary LeFort I Osteotomy
Launched by CHANG GUNG MEMORIAL HOSPITAL · Nov 16, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Background and study purpose:
Patients who received maxillary LeFort I osteotomy often complained about their nose become wider and more nostril show after surgery. According the the literature review, the conventional and modified alar base cinch technique both could control the interalar width. However, there is no long term result show which technique is superior to the other. Therefore, in order to improve patients' nasal and midfacial esthetics after the surgery, this study is to evaluate how the nasal changes affected by 2 different alar base cinch suture and which technique could re...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Taiwanese patients who received LeFort I osteotomy at CGMH during 2011-2012
- • No previous craniofacial surgery
- • Patients agreed to attend this study and willing to sign the agreement
- • Patients who are elder than 18 years old and after growth completion
- Exclusion Criteria:
- • Craniofacial anomalies
- • cleft lip and /or palate patients
- • patients without all the documents
- • patients do not receive combined correcting nasolabial shape and orthognathic surgery.
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Ellen, Wen Ching Ko, DDS,MS
Study Director
Chang Gung MH
YiHsuan Chen, DDS, MS
Principal Investigator
Chang Gung MH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials